| Name | PBRM1-BD2-IN-8 |
|---|---|
| Synonyms |
PBRM1BD2IN8
PBRM1-BD2-IN-8, 10 mM in DMSO 4(1H)-Quinazolinone, 5-bromo-2,3-dihydro-2-(3-methylphenyl) 5-Bromo-2-(m-tolyl)-2,3-dihydroquinazolin-4(1H)-one |
| Description | PBRM1-BD2-IN-8 (compound 34) is a potent PBRM1 Bromodomain inhibitor (PBRM1-BD2 Kd=4.4 μM, PBRM1-BD2 IC50=0.16 μM; PBRM1-BD5 Kd=25 μM). PBRM1-BD2-IN-8 shows anti-cancer activity[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 0.16 μM (PBRM1-BD2)[1] |
| In Vitro | PBRM1-BD2-IN-8 (0-100 μM; 48 h) inhibits the growth of PBRM1-dependent prostate cancer cells[1]. Cell Viability Assay[1] Cell Line: LNCaP cells Concentration: 0-100 μM Incubation Time: 48 hours Result: Inhibited the growth of LNCaP cells with IC50 value of about 9 μM. |
| Molecular Formula | C15H13BrN2O |
|---|---|
| Molecular Weight | 317.18 |